Thursday, January 16, 2025

FDA approves Johnson & Johnson's COVID-19 vaccine for emergency use

FDA approves emergency use of Johnson & Johnson's COVID-19 vaccine, which can be administered to people 18 years of age and older.

Pamela Cruz. Pen sula 360 Press [P360P].

The U.S. Food and Drug Administration?FDA, for its acronym in English? approved this Saturday, on an emergency basis, the Janssen vaccine against COVID-19, manufactured by the pharmaceutical company Johnson & Johnson, which can be administered to people over 18 years of age.

This vaccine is the first that provides immunization in a single dose to be authorized by the US government to counteract the epidemic generated by the SARS-CoV-2 virus.

The statement issued by the FDA indicates that the Janssen vaccine meets the legal criteria for its application in the country.